PRA Group Inc PRAA Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Detail RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Eases KMB Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance